These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 20049796)

  • 1. Nanoparticle therapeutics: a personal perspective.
    McNeil SE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of nanoparticles for therapeutics.
    Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
    Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
    Eifler AC; Thaxton CS
    Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine: nanocarriers shape up for long life.
    Nishiyama N
    Nat Nanotechnol; 2007 Apr; 2(4):203-4. PubMed ID: 18654260
    [No Abstract]   [Full Text] [Related]  

  • 7. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
    Rothenfluh DA; Hubbell JA
    Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of nanotechnology approaches for cardiovascular disease: a personal perspective.
    Buxton DB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):149-55. PubMed ID: 20049786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticulate alternatives for drug delivery.
    Adair JH; Parette MP; Altinoğlu EI; Kester M
    ACS Nano; 2010 Sep; 4(9):4967-70. PubMed ID: 20873786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of researches on drug-loaded nanoparticles].
    Zhao J; Sheng Y; Shan X; Zhang X; Yuan Y; Liu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):220-3. PubMed ID: 18435295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of multifunctional nanomedical systems.
    Haglund E; Seale-Goldsmith MM; Leary JF
    Ann Biomed Eng; 2009 Oct; 37(10):2048-63. PubMed ID: 19169822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of nanotechnology in biomedicine.
    Navalakhe RM; Nandedkar TD
    Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles as nanocarriers.
    Wu SH; Hung Y; Mou CY
    Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering nanocomposite materials for cancer therapy.
    Minelli C; Lowe SB; Stevens MM
    Small; 2010 Nov; 6(21):2336-57. PubMed ID: 20878632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.